Mumbai, 16 May 2024: The Central Drugs Standard Control Organisation (CSDCO) on Wednesday approved Boehringer Ingelheim’s Spevigo (Spesolimab) injection, a first-in-class treatment for adults suffering from Generalised Pustular Psoriasis (GPP) flares -- a rare skin disorder......
View Details

Related News

• Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)

---

• CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)

---

• India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)

---

• US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)

---

• Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)

---

• DCC recommends making Sugam portal database of all products with brand names (17-09-2024)

---

• CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)

---

• One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)

---

• Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)

---

• CDSCO to switch Form 44 submission online (16-09-2024)

---